Wearable tech tracks fatigue in muscle disease patients
NCT ID NCT06666816
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find better ways to measure fatigue and walking problems in people with neuromuscular diseases like muscular dystrophy and spinal muscular atrophy. Researchers will use a wearable sensor to track physical activity for one week in daily life and during a walking test. The goal is to identify objective biomarkers that could help monitor disease progression more accurately.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better tools for tracking fatigue and walking problems in neuromuscular diseases, helping doctors monitor patients more accurately.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to any direct benefit for participants, and the findings might not apply to all types of neuromuscular diseases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHARCOT-MARIE-TOOTH DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Scientific Institute IRCCS E. Medea - Polo di Conegliano
NOT_YET_RECRUITINGConegliano, Treviso, 31015, Italy
-
Scientific Institute IRCCS E. Medea - Sede di Bosisio Parini
RECRUITINGBosisio Parini, Lecco, 23842, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple blood test track nerve damage? a study investigates NT-3 levels in neuropathy.
- Could a simple device ease nerve pain in Charcot-Marie-Tooth?
- Gene study aims to decode rare nerve disorder variations
- New study aims to sharpen tools for tracking becker muscular dystrophy
- New drug could help boys with duchenne walk and move longer
- Gene therapy hope for SMA kids: early trial launches